Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
In 40-50% of patients with essential hypertension, a high sodium intake does not increase renal blood flow (RBF). These patients have been defined as nonmodulators because sodium intake does not modulate renal and adrenal responsiveness to angiotensin II (AII). To define the role of AII in mediating...
Salvato in:
| Pubblicato in: | J Clin Invest |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Clinical Investigation
1985
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC425457/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2985655/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI111828 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
